Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trial

Publication | Closed Access

DOI

1.6K

Citations

References

2019

Year

Howard West, Michael McCleod, Maen Hussein, Alessandro Morabito, Achim Rittmeyer, Henry Jacob Conter, Hans‐Georg Kopp, Davey B. Daniel, Steven McCune, Tarek Mekhail,

The Lancet Oncology

MedicineMetronomic TherapyPharmacologyPathologyBronchial NeoplasmNab-paclitaxel ChemotherapyFirst-line TreatmentCancer TreatmentOncologyRadiation OncologyLung CancerMolecular Oncology